Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine vs Magnesium Sulphate in DHS Fixation
NCT07326397Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexmedetomidine, magnesium sulfate in intertrochanteric femur fracture (ITF), sponsored by Assiut University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
intertrochanteric femur fracture (ITF)
Beyond the preview
Go deeper on NCT07326397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07326397.